Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

First approval for Infergen

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Potential agent for hepatitis enters clinical trials at Bristol-Myers Squibb

Oct. 7, 1997

Nonexclusive licensing opportunity in HCV protease inhibitor research announced by Chiron

Oct. 6, 1997

Byk Gulden presents new gastric antisecretory agents

Oct. 2, 1997

Launch announced for new ulcerative colitis Rx

Oct. 1, 1997

Intron A/ribavirin combination for HCV: preliminary phase III results

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

L-Arginine for liver ischemia/reperfusion injury and transplantation

Sep. 25, 1997

Colonic prokinetic agent discovered by Janssen

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...